Headline
The latest stories from AHA Today.
In response to the significant impact of the COVID-19 pandemic on nursing homes, the Centers for Medicare & Medicaid Services recommended criteria for state and local officials who are considering how to mitigate risks.
The Small Business Administration released the application that borrowers must submit to the lender servicing their Paycheck Protection Program loan to request forgiveness for some or all of the loan.
The CDC awarded $10.25 billion from the Paycheck Protection Program and Health Care Enhancement Act to states, territories and local jurisdictions, and $750 million to tribal health programs to expand COVID-19 testing capacity and related activities.
HHS announced a $354 million agreement with a private partnership to make more active pharmaceutical ingredients and generic drugs in the United States to treat patients hospitalized with COVID-19 and prevent shortages of essential medicines.
The AHA, Association of periOperative Registered Nurses, and AdvaMed released clinically based guidance to support the safe reentry of medical device representatives into hospitals and other surgical facilities as they resume elective surgeries paused during the COVID-19 pandemic.
State Medicaid programs are reporting an uptick in enrollment compared with their fiscal year 2020 projections, due in part to the COVID-19 pandemic.
Infectious virus in feces is a common manifestation of COVID-19, according to a study from China published in the Center for Disease Control and Prevention’s Emerging Infectious Diseases journal.
The Food and Drug Administration authorized the emergency use of Everlywell, Inc.’s COVID-19 Test Home Collection Kit.
The Trump administration introduced Operation Warp Speed, a $10 billion public-private partnership intended to accelerate development, manufacturing and distribution of COVID-19 vaccines, therapeutics and diagnostics by January 2021.
The Department of Health and Human Services has canceled today’s deadline for hospitals and health systems to submit data to inform the agency’s distribution of its supply of remdesivir.